GENFIT Announces Publication in Nature Medicine Confirming the Performance of its NASH Diagnostic Technology
Lille (France); Cambridge (Massachusetts, United States); Zurich (Switzerland); September 26, 2023 – GENFIT (Nasdaq and…
NFT
Theratechnologies Reports Financial Results for the Third Quarter and Nine Months of Fiscal 2023 and Provides Business Updates
Q3 2023 consolidated revenue of $20.9 million, adjusted EBITDA of $2.2 million sBLA for F8…
GENFIT Reports First Half-Year 2023 Financial Results and Provides Corporate Update
Cash, cash equivalents and current financial assets totaled €111.8 million as of June 30, 2023…
GENFIT Reports First Half-Year 2023 Financial Results and Provides Corporate Update
Cash, cash equivalents and current financial assets totaled €111.8 million as of June 30, 2023…
Afterparty Secures $5M in Funding to Debut Afterparty AI; Enables Creators to Infinitely Scale Fan Interactions
LOS ANGELES–(BUSINESS WIRE)–Afterparty, the platform empowering thousands of creators with the tools and technology for…
JETRO to Showcase 10 Japanese Startups at Disrupt 2023 Japan Pavilion
SAN FRANCISCO–(BUSINESS WIRE)–#accelerator–The Japan External Trade Organization (JETRO) will be sponsoring the Japan Pavilion once…
Mineralys Therapeutics Announces JAMA Publication of Full Target-HTN Phase 2 Trial Results for Lorundrostat in Uncontrolled and Treatment-Resistant Hypertension
– Lorundrostat, a highly selective aldosterone synthase inhibitor, demonstrated robust, double-digit reduction in systolic blood…
National Cade Prize for Innovation Names 21 Finalists
GAINESVILLE, Fla.–(BUSINESS WIRE)–Judges for 2023’s National Cade Prize for Innovation named this year’s 21 Fibonacci…
Parexel and Partex Announce Innovative Alliance Leveraging Artificial Intelligence and Big Data to Accelerate Drug Discovery and Development
Collaboration combines clinical research expertise with artificial intelligence capabilities to help drug developers better understand…
Parexel and Partex Announce Innovative Alliance Leveraging Artificial Intelligence and Big Data to Accelerate Drug Discovery and Development
Collaboration combines clinical research expertise with artificial intelligence capabilities to help drug developers better understand…
Grace Breeding Provides Summary Update on Progress Related to its Leading Programs for the First Half of the Year
– Grace Breeding’s environmentally friendly proprietary NFT biofertilizer (Maoz™) receives first approval in Brazil and…
Grace Breeding Provides Summary Update on Progress Related to its Leading Programs for the First Half of the Year
– Grace Breeding’s environmentally friendly proprietary NFT biofertilizer (Maoz™) receives first approval in Brazil and…
Grace Breeding’s Environmentally Friendly WDS Climate Stress Tolerance Solution Receives its First European Product Registration in Germany
– Grace Breeding’s WDS, a proprietary and environmentally friendly formula to counteract crop climate stress,…
Grace Breeding’s Environmentally Friendly WDS Climate Stress Tolerance Solution Receives its First European Product Registration in Germany
– Grace Breeding’s WDS, a proprietary and environmentally friendly formula to counteract crop climate stress,…
CoinFund Hires Leading Transactional Attorney Dilveer Vahali as Head of Venture Legal
Experienced Attorney to Drive CoinFund’s Legal Deal Strategy and Execution NEW YORK–(BUSINESS WIRE)–#CoinFund–Today CoinFund, a…
CoinFund Reinforces Commitment to Web3 Technology with the Close of $158M Seed IV Fund
Firm Celebrates Eight Year Anniversary in July After Raising $550M in the Last 18 Months…
Brazil Field Trials of Grace Breeding’s Environmentally Friendly Maoz™ (NFT Bio-Fertilizer) in Corn Show Trifold Economic Benefit To Farmers While Using 50% Less Urea
Figure 1 Maoz (TM) – Farmer Estimated Potential Additional Income in US$/Ha. (Maize, Brazil) Figure…
AIM ImmunoTech to Participate in the Virtual Investor Summer Spotlight Series
Live moderated video webcast on Wednesday, July 12th at 11:00 AM ET OCALA, Fla., July…
AIM ImmunoTech to Participate in the Virtual Investor Summer Spotlight Series
Live moderated video webcast on Wednesday, July 12th at 11:00 AM ET OCALA, Fla., July…
Ipsen and GENFIT Announce Positive Results from Phase III ELATIVE® trial of elafibranor in patients with primary biliary cholangitis, a rare cholestatic liver disease
Trial met primary endpoint with a statistically significant higher percentage of patients achieving a clinically…